Substance P.
D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D002490:Central Nervous System / Q000032:analysis / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D004064:Digestive System / Q000032:analysis; D005123:Eye / Q000032:analysis; D005728:Ganglia, Sympathetic / Q000032:analysis; D006801:Humans; D018377:Neurotransmitter Agents / Q000502:physiology; D010525:Peripheral Nerves / Q000032:analysis; D011863:Radioimmunoassay; D012137:Respiratory System / Q000032:analysis; D012469:Salivary Glands / Q000187:drug effects; D013329:Structure-Activity Relationship; D013373:Substance P / Q000032:analysis / Q000378:metabolism / Q000494:pharmacology*; D014664:Vasodilation / Q000187:drug effects
D000700:Analgesics; D018377:Neurotransmitter Agents; D013373:Substance P